â€œALS is a terminal disease with very few therapeutic options, so colleagues and I are working on tackling solutions from the outside inâ€
"Having access to a community lab and research services to address a study that is close to my own experience with gout is exciting," said DerekÂ Jacoby, a Ph.D. student at the University of Victoria in British Columbia. "I've tried informal tests on myself using a probiotic method of improving uric acid clearance, and now I'm ready to deepen the research and hopefully bring a new solution to others suffering from this condition."
TheÂ Open Science Challenge was open to all Bay Area residents ages 10 to 110 who wanted to take their research ideas to the next level. Research proposals were reviewed by a committee of BioCurious and Assay Depot employees, and selections were based on scientific significance, proposal quality, a demonstrated need for lab space and services, and location.
"ALS is a terminal disease with very few therapeutic options, so colleagues and I are working on tackling solutions from the outside in," said Ryan Bethencourt, geneticist, biohacker and a founder of Halpin Neurosciences. "In collaboration with Eric Valor, an ALS patient who has driven the at-home version of an investigational therapy called NP001,Â along with the broader ALS community and pioneers in the area, we're determined to advance new treatment options for patients. The BioCurious lab will allow us to do some of the prep work before outsourcing through Assay Depot - together an opportunity for accelerated research that just wasn't possible until now."